Search Ontology:
ChEBI
SB 224289
- Term ID
- CHEBI:64069
- Synonyms
-
- (1'-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4'-piperidin]-5-yl)[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone
- SB224289
- Definition
- A member of the class of benzamides obtained by formal condensation of the carboxy group of 2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1'-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4'-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo.
- References
-
- CAS:180083-23-2
- PMID:18190518
- PMID:19144744
- PMID:19604677
- PMID:20385119
- PMID:20412834
- PMID:21212522
- PMID:21473863
- PMID:21653728
- Patent:US5972951
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from SB 224289
Phenotype where environments contain SB 224289
Phenotype modified by environments containing SB 224289
Human Disease Model